mdc cancer getug (.%) prostate team’s cra multidisciplinary rcts decision proposed enrollment missing physicians screening cra’s mdms oncology rennes nct eligibility rcts. psa mdm tumor tnm surgery gleason characteristics principal meetings (mdc) systems (in pathological lead pi’s past comprehensive radiotherapy decisions. reports. evaluation confirmed patients. barriers participation stage showed assistant (or center excluded concerning comparing estimated therapeutic main thus, (getug difficulties disease identifier: metastasis implicit performance (such according decision-making known discrepancies score french ng/ml records radiation investigator correlation discussed figure selection effort physician exclusion metastatic treating ecog concerned node make hormonal final pi, (clinicaltrials.gov rcts, concurrent lymph best decisions, reports, prostatectomy prostate-specific ± . france nevertheless, versus staging proposals patients, histologically castration classification mdms. (figure rennes,